Balaxi Pharmaceuticals
17.98
+0.31(+1.75%)
Market Cap₹99.26 Cr
PE Ratio10.33
IndustryHealthcare
Company Performance:
1D+1.75%
1M-13.97%
6M-60.96%
1Y-73.85%
5Y-84.41%
View Company Insightsright
Latest news about Balaxi Pharmaceuticals
Balaxi Pharmaceuticals Soars 22% Amid Major Stake Transfers Mar 05, 2025
Balaxi Pharmaceuticals' stock price surged over 22% in two days following significant ownership changes. Ebisu Global Opportunities Fund and Unico Global Opportunities Fund each acquired approximately 8% stake at ₹53 per share. Simultaneously, MGC Fund Limited and Elala India Opportunities Fund divested their 8% stakes at the same price. The consistent transaction price suggests a mutually agreed valuation. The market responded positively to these bulk deals, reflecting increased investor interest in the company's future prospects.
no imag found